Overture Life develops an automated and portable embryology lab that enhances the efficiency of in vitro fertilization (IVF) by standardizing processes and reducing manual intervention. This technology addresses the high costs and low success rates associated with traditional assisted reproductive technologies by improving embryo selection and increasing accessibility to fertility treatments.
Funding
$52.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional in vitro fertilization (IVF) processes are largely manual, leading to variability in best practices, high costs, and relatively low success rates. The lack of standardized procedures and reliance on manual intervention limit the scalability and accessibility of fertility treatments.
Solution
Overture Life offers an automated and portable embryology lab designed to standardize IVF processes and minimize manual intervention. Their technology aims to improve embryo selection and increase the efficiency of assisted reproductive technologies (ART), ultimately reducing costs and enhancing accessibility to fertility treatments. By automating key steps in the IVF process, Overture Life seeks to improve outcomes and transform fertility treatment for a broader range of individuals.
Target Audience
The primary target audience includes fertility clinics, embryologists, and other professionals in the field of assisted reproductive technology seeking to improve IVF outcomes and reduce costs.
Features
- DaVitri: An automated and portable embryology lab.
- m|z: Metabolomic profiling of embryos.
- ICSI.A: Automated Piezo ICSI (Intracytoplasmic Sperm Injection).